deaths (OS) (extension)

es-BC - TNBC - NA - all population breast cancer - triple negative es-BC - Triple negatif (TNBC) - (neo)adjuvant (NA) es-BC - TNBC - NA - all population

versus placebo
durvalumab alone vs. placebo 1 certainty unassessable-70%